Data From Two High-Dose Chemo/Transplant Studies to Be Released
BETHESDA, Md-The National Cancer Institute (NCI) announced that preliminary findings from two long-awaited breast cancer studies are expected to be made available April 15 on the American Society of Clinical Oncology (ASCO) website (www.asco.org).
BETHESDA, MdThe National Cancer Institute (NCI) announced that preliminary findings from two long-awaited breast cancer studies are expected to be made available April 15 on the American Society of Clinical Oncology (ASCO) website (www.asco.org).
The two NCI-sponsored studies address the effectiveness of high-dose chemotherapy and autologous bone marrow or stem cell transplants in the treatment of breast cancer. NCI said more fully analyzed data from the two studies would be presented at the ASCO meeting in Atlanta, May 1518, along with results from two similar European studies.
NCI made its announcement after a meeting with researchers, ASCO representatives, and patient advocacy groups called to determine when reliable data could be released.
